GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » Research & Development

GENFF (Genflow Biosciences) Research & Development : $1.46 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Genflow Biosciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Genflow Biosciences's Research & Development for the six months ended in Jun. 2024 was $1.19 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was $1.46 Mil.

Genflow Biosciences Research & Development Historical Data

The historical data trend for Genflow Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Research & Development Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Research & Development
0.11 0.88 1.22 1.46

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial 0.76 0.52 0.69 1.19 0.27

Genflow Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences  (OTCPK:GENFF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genflow Biosciences Research & Development Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » Research & Development
Comparable Companies
LSE:BSFA LSE:TCF LSE:CRTX LSE:ROQ LSE:APTA LSE:NFX LSE:CIZ LSE:VAL AQSE:INC LSE:PYC VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
GENF:UK
Address
6 Heddon Street, London, GBR, W1B 4BT
Website
https://www.genflowbio.com
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.